Vasculitis & polymyalgia rheumatica

Assessing vasculitis in Takayasu arteritis by ultrasound: results of OMERACT patient-based reliability exercises

RMD OpenPublished live patient-based reliability exercises

Authors' conclusion

Among the ultrasound elementary lesions for TAK, the ‘macaroni sign’ revealed moderate to good reliability, while the reproducibility of stenosis and occlusion was worse and more variable. These results provide the methodological basis to develop a new global Outcome Measures in Rheumatology (OMERACT) ultrasound score in TAK.

Study context

Population
Patients with Takayasu arteritis (TAK) and a control subject examined by vascular sonographerseach exercise involved 12 vascular sonographers who examined five patients with TAK and one control subject
Outcome
Inter-rater reliability (Fleiss' κ) across the two rounds of both exercises
Methodological detailstwo live exercises with two rounds each, independent examination
  • Two live exercises with two rounds each
  • Independent examination

Main finding

As reported in the abstract

'macaroni sign' (moderate to good)

κ 0.51-0.74

Stenosis (fair)

0.24-0.38

Occlusion (variable)

0.02-0.60

Further findings

Intrarater reliability (Cohen's κ) across the two exercises

'macaroni sign' (good to excellent)
0.74-0.81
Stenosis (moderate)
0.55-0.64
Occlusion (moderate)
0.64-1.00
  • Occlusion based on a limited number of assessments

Reliability per vessel and lesion

Inter-rater reliability good to excellent for the 'macaroni sign' in carotids but worse across other vessels and lesion types
Intrarater reliability good to excellent per single vessel and lesion though limited for occlusions and for the abdominal aorta

Original publication

Assessing vasculitis in Takayasu arteritis by ultrasound: results of OMERACT patient-based reliability exercises. RMD Open. Published 30 October 2026. doi:10.1136/rmdopen-2026-006884

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.